Richard L. Lindstrom M.D., Director at OCULAR THERAPEUTIX, INC (OCUL), bought 60,229 shares at $7.66 ($461K) on 2026-02-20, disclosed to the SEC on 2026-02-24.
Open-market purchase of $461k OCUL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| HROW | SELL | 2021-09-27 | $39K | — | Filing → |
| HROW | SELL | 2021-09-17 | $363K | — | Filing → |
| HROW | SELL | 2021-05-21 | $108K | — | Filing → |